RELATION OF HEART RATE AND BETA BLOCKER OR IVABRADINE USE IN PATIENTS WITH NEWLY DIAGNOSED HEART FAILURE WITH REDUCED LVEF
نویسندگان
چکیده
منابع مشابه
Beta-blocker use in decompensated heart failure.
Despite the current advances in treatment, acute decompensated heart failure accounts for more than 1 million hospital admissions annually. Many of the patients hospitalized are already receiving long-term treatment with beta-blockers. For patients who receive full dose beta-blocker therapy and suffer acute decompensated heart failure, clinicians face two key questions: what to do, if anything,...
متن کاملBeta-Blocker Therapy and Cardiac Events Among Patients With Newly Diagnosed Coronary Heart Disease
Fro Po Ca Me Am Te con Lis Yo Ma BACKGROUND The effectiveness of beta-blockers for preventing cardiac events has been questioned for patients who have coronary heart disease (CHD) without a prior myocardial infarction (MI). OBJECTIVES The purpose of this study was to assess the association of beta-blockers with outcomes among patients
متن کاملBeta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure.
25% higher in this treatment arm. This would be expected from previous large-scale beta-blocker trials. Any additional agent on top of what is already working may yield a smaller incremental effect as the investigators also demonstrated in the perindoprilinitiated arm. What this “humble” study confirms are that beta-blockers are important in patients with NYHA functional class II or above, that...
متن کاملProphylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia
Health technology The study compared two treatment strategies for patients with chronic heart failure (CHF). The strategies compared were the conventional strategy and the pacemaker-carvedilol strategy. In the conventional strategy, patients were treated with angiotensin-converting enzyme inhibitors, diuretics and digoxin. In the pacemaker-carvedilol strategy, patients received conventional tre...
متن کاملProphylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia.
BACKGROUND Although the benefits of beta-blocker therapy for patients with congestive heart failure (CHF) are independent of pretreatment heart rate, patients with chronic systolic heart failure and low resting heart rates are often excluded from beta-blocker therapy. We investigated the effectiveness and cost-effectiveness of prophylactic pacemaker insertion to facilitate beta-blocker use in t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2021
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(21)02092-1